Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel safe synthesis method for high purity intermediate. Reduces cost and risk. Reliable supply chain for pharmaceutical manufacturing.
Patent CN113620811A reveals a metal sulfonate catalyzed method for high-selectivity ortho-halogenation, offering cost-effective manufacturing for pharmaceutical intermediates.
Patent CN113121323B reveals a high-yield, two-step synthesis of p-hydroxybenzaldehyde using aluminum/zinc salts and copper ferrite, offering significant cost reduction and supply chain stability.
Patent CN119264121A reveals Ru-catalyzed C-H activation for high-purity benzopyrone derivatives. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110143982A reveals green synthesis. Cost reduction and supply reliability for high-purity organophosphorus intermediates in global markets.
Novel electrochemical route for tetrahydrofuran intermediates eliminates oxidants. Offers green manufacturing and scalable supply for pharmaceutical applications globally.
Novel linear alkane solvent method improves lidocaine purity to 99.8%. Reduces impurities and enables mother liquor recovery for cost efficiency.
Advanced stereoselective preparation of Sofosbuvir intermediates via patent CN105153257B. Reduces production costs and enhances supply chain reliability for global pharmaceutical manufacturers.
Patent CN111690947A details a green electrochemical method for trifluoromethylated aryl amides, offering metal-free synthesis and high yields for reliable pharmaceutical intermediate supply chains.
Patent CN115652344A reveals a metal-free electrochemical route for eight-membered selenium-containing benzoazacycles, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN104876889B reveals a high-yield Mirabegron route eliminating toxic borane. This ensures cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN115947690B reveals metal-free indazole synthesis with high yield. Offers cost reduction and supply chain stability for pharmaceutical intermediates manufacturing.
Novel patent CN119306612A enables high trans-selectivity. Reduces waste and cost for pharmaceutical intermediate manufacturing supply chains.
Novel 2-fluoroadenine synthesis patent CN105130989A offers high yield and safety. Enables cost reduction in pharma manufacturing and reliable supply chain for antiviral drugs.
Patent CN106967055A reveals efficient Mn-catalyzed route. Delivers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN111978216A details a copper-catalyzed method for beta-carbonyl sulfones. Offers mild conditions, high yield up to 93%, and broad substrate scope for pharmaceutical manufacturing.
Advanced preparation of 2-(2-aminoethoxy)-1,1-dimethoxyethane via CN113527119A. Offers high purity, simplified isolation, and cost-effective manufacturing for influenza drug supply chains.
Novel copper-catalyzed synthesis ensures high yield and beta-configuration. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113235116B reveals a green electrochemical method for bromopyridine derivatives, offering cost reduction and high purity for pharmaceutical manufacturing without metal catalysts.
Patent CN110105362B details a safe, high-yield folic acid synthesis using heteropoly acid catalysts, eliminating hazardous chlorination for reliable API intermediate supply.